Pharm Exec speaks to Florent Edouard, SVP and global head of commercial excellence at the Gr nenthal group, and Jan van den Burg, vice president for commercial strategy at Veeva in Europe, about how the COVID-19 pandemic is changing the way the industry reaches and engages with its customers.Original Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.